Single-agent high-dose melphalan followed by peripheral blood stem cell (PBSC) in lymphoma patients: an effective, and well-tolerated conditioning regimen.

Source:http://linkedlifedata.com/resource/pubmed/id/15129236

Download in:

View as

General Info

PMID
15129236